IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Por um escritor misterioso
Descrição
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency: Cell
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses - ScienceDirect
Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
de
por adulto (o preço varia de acordo com o tamanho do grupo)
